Navigation Links
Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists 'Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus'
Date:4/15/2008

inhibitor. Welchol is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Welchol should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis. It has not been studied in type 2 diabetes as monotherapy or in combination with a dipeptidyl peptidase 4 inhibitor and has not been extensively studied in combination with thiazolidinediones. Welchol has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias.

Welchol is contraindicated in individuals with bowel obstruction, those with serum triglyceride (TG) concentrations of >500 mg/dL, or with a history of hypertriglyceridemia-induced pancreatitis.

The effect of Welchol on cardiovascular morbidity and mortality has not been determined.

Welchol can increase serum TG concentrations particularly when used in combination with sulfonylureas or insulin. Caution should be exercised when treating patients with TG levels >300 mg/dL.

Welchol may decrease the absorption of fat-soluble vitamins A, D, E, and K. Patients on vitamin supplements should take their vitamins at least 4 hours prior to Welchol. Caution should be exercised when treating patients with a susceptibility to vitamin K or fat soluble vitamin deficiencies.

Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders.

Welchol reduces gastrointestinal absorption of some drugs. Drugs with a known interaction with colesevelam (glyburide,levothyroxine, and oral contraceptives [ethinyl estradiol, norethindrone]) should be administered at least 4 hours prior to Welchol. Drugs that have not been tested for interaction with colesevelam, especially those with a narrow therapeutic index, should also be administered at least 4 hours prior to Welchol. Altern
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
2. Corals added to IUCN Red List of Threatened Species for first time
3. Halozyme Therapeutics Added to Nasdaq Biotech Index
4. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. An Event Added to Celebrate and Empower North Carolina Women
6. Blood pressure drug may have added benefit
7. VA Has Added 20 New Vet Centers
8. Turner Investment Partners Added to AHA Diversified Equity Fund
9. Kelsey Grammer, Ben Stiller, Maroon 5 and The Roots Added to COMEDY CENTRALs(R) Live On-air Charity Special Night of Too Many Stars: An Overbooked Concert for Autism Education Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET
10. IPC The Hospitalist Company Added to Russell 2000 Index
11. Many Older Americans Have Active Sex Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® will team ... America (HCA), as it further expands its Strategic Alliance Partnership Program for raising ... new partnership, OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility ... Health Month, and we at Advanced Fertility Center of Texas (AFCT) would like to ... , While infertility is often considered to be a “woman’s issue,” male fertility factors ...
(Date:7/1/2015)... TX (PRWEB) , ... July 01, 2015 , ... As ... another symptom found in a significant number of women: leg pain. Northeast Houston Vein ... , Leg pain, a symptom of venous reflux disease, is underdiagnosed and often overlooked. ...
(Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD holds ... and continued at USF earning a Master’s degree in Microbiology. He graduated from the ... the American Dental Association, the Florida Dental Association and the Academy of General Dentistry. ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... provider of IBM software products, announced today that it has received trademark protection ... integration, display and detailed analysis of data from multiple sources providing an environment ...
Breaking Medicine News(10 mins):Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
... a catastrophic epidemic of smoking deaths, which is expected to cause ... including one in five of all male deaths and one ... male bidi smokers lose about six years of life, female bidi ... ten years. , The findings are from the first nationally ...
... ReBuilder Medical,Technologies, Inc. (Pink Sheets: RBRM), ... for diabetic peripheral neuropathy, Molluscum,Contagiosum, and MRSA, ... year, details,are available on their Annual Report ... http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ), "The company,s growth ...
... German trial could be a breakthrough treatment in vascular ... stents haven,t worked well for blocked leg arteries, but ... balloons, which are inserted at the end of catheters ... whose balloons were coated with paclitaxel, one of the ...
... Approves Stock Repurchase Program, Raising 2008 EPS Guidance to $2.58 to $2.73 ... ... BEACH, Va., Feb. 13 AMERIGROUP,Corporation (NYSE: AGP ) today announced ... $31.1 million, or $0.57 per diluted,share, versus net income of $29.9 million, ...
... Feb. 13 Watson,Pharmaceuticals, Inc. (NYSE: WPI ... the U.S. Food and Drug Administration ("FDA"),has initiated ... regarding the duration or outcome of the inspection ... Florida manufacturing facility has,been under Official Action Indicated ...
... trauma disorder as good a marker for health status as ... People with post-traumatic stress disorder (PTSD) are as likely to ... disease risk factors, a new study suggests. , The findings, ... of Nervous and Mental Disease , come from examining the ...
Cached Medicine News:Health News:India caught in catastrophic smoking epidemic 2Health News:India caught in catastrophic smoking epidemic 3Health News:ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006 2Health News:Drug-Coated Balloons Keep Leg Arteries Open: Study 2Health News:Drug-Coated Balloons Keep Leg Arteries Open: Study 3Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 2Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 3Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 4Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 5Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 6Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 7Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 8Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 9Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 10Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 11Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 12Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 13Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 14Health News:AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share 15Health News:Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities 2Health News:PTSD a Risk Factor for Long-Term Disease 2
(Date:7/1/2015)... , June 24, 2015 ... ) has announced the addition of the ... Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging ... offering. 2015 New Frontiers in ... Challenges, Emerging Technologies, Competitive Landscape is a ...
(Date:7/1/2015)... WAYNE, Pa. , July 1, 2015 ... services and education, announced today that, as part of ... into an agreement to be acquired by investment firm ... outside private equity investors, Altaris Capital Partners and NewSpring ... founded in 1999, has assisted nearly 5,000 healthcare facilities ...
(Date:7/1/2015)...  goBalto, Inc., the leading provider of cloud-based ... in serving pharmaceutical, biotech and CRO companies. ... trials and restrain costs, but inefficiencies tied to ... these efforts," said Sujay Jadhav , goBalto,s ... encouraged Industry leaders, to embrace cloud-based solutions. Our ...
Breaking Medicine Technology:2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 3goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2
... NEW YORK, Oct. 11, 2011 PLC Medical Systems, ... RetailInvestorConferences.com presentation is available for on-demand viewing. ... "register/ watch event now" button. PLC Medical ... Investors may download shareholder materials from the "virtual trade ...
... 11, 2011 I-Flow announced today ... purchasing agreement by HealthTrust Purchasing Group, L.P. (HealthTrust), ... covers I-Flow,s flagship ON-Q® products for incisional, nerve ... PainBuster®, ON-Q® SilverSoaker™ Catheters and ON-Q® disposable and ...
Cached Medicine Technology:PLC Medical Systems CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2I-Flow LLC, a Kimberly-Clark Health Care Company Announces Agreement for ON-Q® Products With HealthTrust Purchasing Group 2
Pneumatic micro sagittal saw, 30k cpm, available with various hose connector styles....
... 1000 Power Instrument System is a small ... with modular and unitized handpieces.,The head modules ... or pneumatic motor, giving you the flexibility ... the motor. Now you can add instruments ...
... The SmartDriver System consists ... in Pneumatic, Electric and Battery ... of couplers that can be ... orthopedic surgical applications., ,Smartdriver ...
... new large power line from MicroAire. ... cordless AND electric instruments, offering the ... the industry has always wanted with ... Power Master oscillating saw, ...
Medicine Products: